NEW YORK--(BUSINESS WIRE)--Manhattan Scientifics, Inc. (OTCQB:MHTX) announced today that its Senior Scientific, LLC unit, a nanobiotechnology company for the early detection and localization of cancer and other human diseases, has been granted an additional United States Patent for its MRX™ cancer detection technology. U.S. Patent No. US 9,095,270 B2 entitled "Detection, measurement, and imaging of cells such as cancer and other biologic substances using targeted nanoparticles and magnetic prop
For more information, please visit
http://www.businesswire.com/news/home/20[...]nce-Additional-Patent-Covering